Praxis Precision Medicines, Inc. (PRAX)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$262.59-7.80%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · PRAX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | 8.6 | 2.4 | 0.0 | — | — |
| Total Revenues | — | — | 8.6 | 2.4 | 0.0 | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 290.7 | 267.1 | 152.4 | 86.8 | 155.0 | 120.3 | 45.0 |
| Operating Income | (378.2) | (326.2) | (200.2) | (126.4) | (215.0) | (167.3) | (62.0) |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | 39.0 | 22.9 | 17.3 | 3.1 | 1.0 | 0.3 | 0.1 |
| EBT, Incl. Unusual Items | — | (302.8) | — | (123.0) | — | (167.1) | (61.8) |
| Income Tax Expense | — | 0.5 | — | — | — | 0.0 | (0.0) |
| Net Income | |||||||
| Net Income | (338.9) | (303.3) | (182.8) | (123.0) | (214.0) | (167.0) | (61.8) |
| Per Share | |||||||
| Basic EPS | (11.63) | (13.48) | (10.21) | (18.69) | (69.65) | (3.94) | (7.86) |
| Diluted EPS | (11.63) | (13.48) | (10.21) | (18.69) | (69.65) | (3.94) | (7.86) |
| Basic Weighted Avg Shares | 29.1 | 22.5 | 17.9 | 6.6 | 3.1 | 42.5 | 9.0 |
| Diluted Weighted Avg Shares | 29.1 | 22.5 | 17.9 | 6.6 | 3.1 | 42.5 | 9.0 |
| Supplemental | |||||||
| EBIT | (378.2) | (326.2) | (200.2) | (126.4) | (215.0) | (167.3) | (62.0) |
| Effective Tax Rate | — | — | — | — | — | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.